Should You Buy Lumexa Imaging Holdings Inc (LMRI) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast LMRI stock price to rise
8 Analyst Rating
Wall Street analysts forecast LMRI stock price to rise
8 Buy
0 Hold
0 Sell
Strong Buy
Current: 7.780
Low
22
Averages
22.71
High
23
Current: 7.780
Low
22
Averages
22.71
High
23
Barclays
Overweight
downgrade
$15 -> $9
AI Analysis
2026-05-20
Reason
Barclays
Price Target
$15 -> $9
AI Analysis
2026-05-20
downgrade
Overweight
Reason
Barclays lowered the firm's price target on Lumexa Imaging to $9 from $15 and keeps an Overweight rating on the shares. The firm says RadNet is outperforming Lumexa on advanced volume growth and imaging segment pricing.
Barclays
Overweight
downgrade
$23 -> $15
2026-04-14
Reason
Barclays
Price Target
$23 -> $15
2026-04-14
downgrade
Overweight
Reason
Barclays lowered the firm's price target on Lumexa Imaging to $15 from $23 and keeps an Overweight rating on the shares after meeting with management. The company reiterated its 2026 outlook, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for LMRI
